相似文献
1
Erythropoietin and renal protection.
Daru. 2013 Dec 20;21(1):78. doi: 10.1186/2008-2231-21-78.
2
Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients.
Cell J. 2014 Winter;15(4):378-80. Epub 2013 Nov 20.
3
Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial).
Anesthesiology. 2014 Sep;121(3):582-90. doi: 10.1097/ALN.0000000000000321.
4
Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
Am J Physiol Renal Physiol. 2008 Jun;294(6):F1354-65. doi: 10.1152/ajprenal.00131.2008. Epub 2008 Apr 2.
5
Erythropoietin and organ protection: lessons from negative clinical trials.
Crit Care. 2014 Sep 11;18(5):526. doi: 10.1186/s13054-014-0526-9.
6
Recombinant Erythropoietin Provides Protection against Renal Fibrosis in Adenine-Induced Chronic Kidney Disease.
Mediators Inflamm. 2020 Feb 27;2020:8937657. doi: 10.1155/2020/8937657. eCollection 2020.
7
Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events.
Transpl Int. 2014 Mar;27(3):241-8. doi: 10.1111/tri.12174. Epub 2013 Aug 22.
8
Recombinant human erythropoietin pretreatment alleviates renal glomerular injury induced by cardiopulmonary bypass by reducing transient receptor potential channel 6-nuclear factor of activated T-cells pathway activation.
J Thorac Cardiovasc Surg. 2013 Sep;146(3):681-7. doi: 10.1016/j.jtcvs.2013.02.076. Epub 2013 Mar 25.
9
Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models.
J Am Soc Nephrol. 2016 Nov;27(11):3394-3404. doi: 10.1681/ASN.2015091059. Epub 2016 Mar 16.
10
JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells.
Am J Physiol Renal Physiol. 2008 Dec;295(6):F1689-95. doi: 10.1152/ajprenal.90333.2008. Epub 2008 Sep 24.
本文引用的文献
1
Novel renoprotection methods by local and remote conditioning.
J Renal Inj Prev. 2013 Nov 3;3(2):37-8. doi: 10.12861/jrip.2014.12. eCollection 2014.
2
Erythropoietin; a review on current knowledge and new concepts.
J Renal Inj Prev. 2013 Oct 10;2(4):119-21. doi: 10.12861/jrip.2013.38. eCollection 2013.
3
Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease.
J Renal Inj Prev. 2013 Sep 1;2(3):107-8. doi: 10.12861/jrip.2013.34. eCollection 2013.
4
Does erythropoietin slow progression of chronic kidney disease?
J Renal Inj Prev. 2013 Jun 1;2(2):81-2. doi: 10.12861/jrip.2013.25. eCollection 2013.
5
Acute kidney injury and renal angina.
J Renal Inj Prev. 2013 Jun 1;2(2):33-4. doi: 10.12861/jrip.2013.12. eCollection 2013.
6
Preventive role of erythropoietin against aminoglycoside renal toxicity induced nephropathy; current knowledge and new concepts.
J Renal Inj Prev. 2013 Mar 1;2(1):29-30. doi: 10.12861/jrip.2013.10. eCollection 2013.
7
Histopathological study of the combination of metformin and garlic juice for the attenuation of gentamicin renal toxicity in rats.
J Renal Inj Prev. 2013 Mar 1;2(1):15-21. doi: 10.12861/jrip.2013.07. eCollection 2013.
8
Protection of renal tubules against gentamicin induced nephrotoxicity.
J Renal Inj Prev. 2013 Mar 1;2(1):5-6. doi: 10.12861/jrip.2013.03. eCollection 2013.
9
Protective effect of high dose short term statin therapy with normal saline in prevention of contrast-induced nephropathy among iodixanol-receiving patients.
J Renal Inj Prev. 2012 Jan 1;1(1):43-5. doi: 10.12861/jrip.2012.15. eCollection 2012.
10
Renal protective effect of selenium on cisplatin-induced nephrotoxicity.
J Renal Inj Prev. 2012 Jan 1;1(1):31-2. doi: 10.12861/jrip.2012.11. eCollection 2012.
Zotero 插件